Pediatric Blood and Cancer - McMaster Experts

publication venue for

Cost-utility of nelarabine for the first-line treatment of newly diagnosed pediatric T-cell acute lymphoblastic leukemia in Canada. 2025
A MULTISITE LONGITUDINAL STUDY OF ENGAGEMENT IN CARE OF ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER: PREDICTORS OF ENGAGEMENT AFTER ONE YEAR 2023
ASSOCIATION OF LATE EFFECTS BURDEN AND KNOWLEDGE ON HEALTH RISK BEHAVIORS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER 2023
CENTRAL VENOUS LINE (CVL) DYSFUNCTION AND INFECTIONS ARE INDEPENDENT RISK FACTORS FOR THROMBOEMBOLISM DURING PRIMARY CANCER THERAPY IN CHILDREN: A PROVINCIAL PROSPECTIVE COHORT STUDY 2023
DEVELOPMENT AND EXPANSION OF A CANADIAN SURVEILLANCE POPULATION HEALTH TOOL FOR CHILDREN AND YOUTH WITH CANCER 2023
HIGH QUALITY CARE CLOSE TO HOME: THE POGO SATELLITE PROGRAM 2023
IMPROVING ACCESS TO HIGH-POTENTIAL PEDIATRIC PRECISION THERAPIES: A CHILD-TAILORED ASSESSMENT FRAMEWORK TO DETERMINE VALUE FOR FUNDING DECISIONS 2023
INCREASED PROBABILITY OF RELAPSE ASSOCIATED WITH THROMBOEMBOLISM AND BLOODSTREAM INFECTIONS DURING PRIMARY CANCER THERAPY IN CHILDREN: RESULTS OF A PROVINCIAL PROSPECTIVE STUDY 2023
PHYSICAL ACTIVITY BARRIERS AND FACILITATORS AMONG ADOLESCENTS AND YOUNG ADULTS WITH CANCER: A MIXED METHODS STUDY 2023
RELAPSED WILMS TUMOR MANAGEMENT AND OUTCOMES IN CANADA 2023
Addressing adherence to guidelines on prevention of acute chemotherapy‐induced nausea and vomiting in pediatric patients 2023
CREATING AND ADAPTING AN INFECTION MANAGEMENT CARE PATHWAY IN PEDIATRIC ONCOLOGY 2022
EPIDEMIOLOGY OF CENTRAL VENOUS LINE (CVL) DYSFUNCTION IN CHILDREN WITH CANCER: RESULTS OF A PROVINCIAL PROSPECTIVE COHORT STUDY 2022
NUTRITIONAL STATUS OF GUATEMALAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND THEIR SIBLINGS. A STUDY OF THE RELATIVE IMPACTS OF DISEASE AND SOCIO-ECONOMIC STATUS (SES) 2022
PREDICTORS OF PRE-MAINTENANCE DELAYS DURING THERAPY AND ASSOCIATIONS WITH OUTCOME AMONG CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED STUDY 2022
SAFETY AND EFFICACY OF ALENDRONATE TO TREAT OSTEOPENIA IN CHILDREN DURING THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA 2022
Bone health in long-term survivors of pediatric acute lymphoblastic leukemia. An assessment by peripheral quantitative computed tomography 2021
Bone Health in Long-Term Survivors of Acute Lymphoblastic Leukemia (ALL) Addressed by Peripheral Quantitative Computed Tomography (PQCT) 2021
Development and Validation of a Childhood Acute Lymphoblastic Leukemia Policy Model Constructed Using Real World Population-Based Data 2021
Healthcare Utilization and Costs Associated with Acute Lymphoblastic Leukemia (ALL) in Children with and without Down Syndrome (DS): A Population-Based Study 2021
The First Wave of The Covid-19 Pandemic Did Not Affect Childhood Cancer Incidence In Canada: A Report from Cyp-C 2021
OUTCOMES PREDICTORS OF INFANT ALL, HYPODIPLOID ALL AND MPAL IN CANADA: A POPULATION-BASED STUDY 2021
PEDIATRIC AND ADULT JOINT HEMOGLOBINOPATHY CLINIC: AN EXPERIENCE OF SEAMLESS TRANSITION OF CARE 2021
PHASE-SPECIFIC RISKS OF EMERGENCY VISITS AND HOSPITALIZATIONS DURING COG-BASED ALL TREATMENT 2021
Body Composition of Children With Acute Lymphoblastic Leukemia (ALL) in Guatemala. An Assessment by Dual Energy X Ray Absorptiometry (DXA) 2020
Developing and Validating Clinical Prediction Models for Symptomatic Fractures and Low Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia 2020
Performance of an Ehealth Decision Support Tool (MIPOGG) for Identifying Children With Constitutional Mismatch Repair Deficiency, DICER1 Syndrome, Gorlin Syndrome and Li-Fraumeni Syndrome 2020
The Cancer in Young People in Canada Data Tool: An Interactive Display of the Incidence, Survival, and Recurrence of Childhood Cancer in Canada, 2001-2016 2020
Virtual Peer-to-Peer Mentoring for Adolescents With Cancer: A Pilot Randomized Controlled Trial of the iPeer2Peer Program 2020
Inter-Relationships of Bone Mineral Density with Fat Mass and Fat-Free Mass in Long Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence 2019
Performance of an E-Health Decision-Support Tool for Identifying Cancer Predisposition Syndromes in Canadian Pediatric Oncology Centres 2019
COMPARISON OF HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONING REGIMENS FOR PEDIATRIC HLH 2019
HIGH VS. LOW-INTENSITY BRIDGING CHEMOTHERAPY WHEN AWAITING CAR-T THERAPY: A POPULATION- BASED STUDY 2019
IMPACT OF CHILDHOOD CANCER DRUG WASTAGE ON PEDIATRIC ONCOLOGY PROGRAMS IN ONTARIO, CANADA 2019
PREVALENCE OF LOW VELOCITIES ON TRANSCRANIAL DOPPLER IN CHILDREN WITH SICKLE CELL DISEASE 2019
PROGNOSTIC DETERMINANTS IN CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF DFCI 05001 2019
QUALITY OF LIFE IS THE MOST IMPORTANT INDICATION FOR SECOND-LINE ITP TREATMENT IN CHILDREN 2019
VITAMIN D DEFICIENCY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA: RESULTS OF DFCI 11-001 2019
Assessment of Nutritional Capacity in Pediatric Oncology Units in India: A Survey Report Based on the Framework Established by SIOP PODC Nutrition Working Group 2018
Challenges in Undertaking a Multi-Center Prospective, Observational, Cohort Study in the Pediatric Oncology Population 2018
Comparison of Interventions and Outcomes in Following a Nutritional Algorithm to Conventional Approaches in Children Undergoing Chemotherapy for Cancer 2018
Social Values and Public Policy on Cancer Drug Funding Decisions for Children in Canada 2018
Societal Values and Child Health Priorities: Empirical Evidence for Paediatric Cancer Drug Policy 2018
Thrombo-Embolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study 2018
Towards Improved Cancer Care for the 15 to 39 Year Age Group in Canada: Achievements of the Canadian AYA Cancer Task Force 2018
USE OF EXTRACORPOREAL MEMBRANE OXYGENATION IN A PATIENT WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA DESPITE COAGULOPATHY AND HEMORRHAGE 2018
Adolescent and Young Adult (AYA) Cancer Care in Canada: Highlights from A Report on System Performance Metrics 2017
An Exploratory Analysis of Physical Activity on Modifiable Aging-Related Risk Factors Among Survivors of Childhood Cancer 2017
Nutritional Status of Children with Cancer at Diagnosis in Brazil 2017
Sarcopenic Obesity in Long Term Survivors of Acute Lymphoblastic Leukemia (ALL) 2017
International Survey of the Management of Disseminated Intravascular Coagulation Among Pediatric and Neonatal Health Care Practitioners 2017
Prevalence of Hemoglobinopathies among Ontario Children after the Implementation of Universal Hemoglobinopathy Screening 2017
Assessing Public Opinion of Abandonment of Conventional Treatment for Traditional and Complementary Medicine in Paediatric Oncology: Methodology of a Grey Literature Review 2016
Baseline Clinical and Laboratory Features Predict Risk of Developing Symptomatic Thromboembolism (STE) During Antileukemic Therapy in Children with De Novo Acute Lymphoblastic Leukemia (ALL) 2016
Caregiver Burden and Psychiatric Morbidities Among Informal Caregivers of Children with Cancers in Lagos, Nigeria 2016
Design and Implementation of Comprehensive Inpatient and Outpatient CPOE in a Paediatric Oncology Centre 2016
Improving Influenza Vaccination Rates in Paediatric Oncology Patients and their Caregivers: A Quality Improvement Initiative 2016
Nutritional Status at Diagnosis Predicts Long Term Survival in Children and Adolescents with Cancer in Central America 2016
Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Children: A Multi-Centre Feasibility Study 2016
Stigma and Reactions of Family Caregivers to Childhood Cancers 2016
The Prevalence of Osteonecrosis is High after Treatment for Acute Lymphoblastic Leukemia 2016
Where have all the Fat Cells Gone? A Comparative Analysis of Adiposity Patterns in Paediatric Brian Tumour Patients and Non-Cancer Controls 2016
FATIGUE IN PEDIATRIC IMMUNE THROMBOCYTOPENIA (ITP): BASELINE PREVALENCE IN PATIENTS STARTING SECOND LINE THERAPIES IN THE FIRST ITP CONSORTIUM OF NORTH AMERICA RESEARCH STUDY (ICON1) 2016
MINIMALLY INVASIVE SURGICAL RESECTION AND BUCCAL GRAFT VAGINOPLASTY WITHOUT RADIOTHERAPY (RT) FOR DEFINITIVE LOCAL CONTROL IN GIRLS WITH VAGINAL BOTRYOID RHABDOMYOSARCOMA (RMS) 2016
VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE FOR RELAPSED RHABDOMYOSARCOMA 2016
CHILD SYMPTOM BURDEN AND DEPRESSIVE SYMPTOMS AMONG CAREGIVERS OF CHILDREN WITH CANCERS 2015
EARLY POST-OPERATIVE MRI FOLLOWING A RESECTION OF A PEDIATRIC BRAIN TUMOR - WHAT IS THE RIGHT TIMEPOINT? 2015
HEALTH-RELATED QUALITY OF LIFE IN LONG-TERM SURVIVORS OF BRAIN TUMOURS IN CHILDHOOD AND ADOLESCENCE: A SERIAL STUDY SPANNING A DECADE 2015
LONG-TERM FUNCTIONAL OUTCOMES OF HYPERFRACTIONATED RADIATION ON CHILDHOOD ALL SURVIVORS: A PILOT STUDY 2015
OBSTRUCTIVE SLEEP APNEA IN SURVIVORS OF PEDIATRIC BRAIN TUMOURS 2015
OUTCOME OF NEUROFIBROMATOSIS TYPE 1 PATIENTS TREATED WITH FIRST LINE VINBLASTINE FOR OPTIC PATHWAY GLIOMAS (OPG): A CANADIAN MULTICENTER STUDY 2015
QUALITY OF LIFE IN CHILDREN WITH LOW-GRADE GLIOMA RECEIVING VINBLASTINE AS FIRST-LINE TREATMENT: A CANADIAN MULTICENTER STUDY 2015
RADIATION NECROSIS IN CHILDREN - AN UNDERREPORTED PROBLEM?! 2015
THE EFFECTIVENESS OF LIFESTYLE INTERVENTION, PHARMACOTHERAPY OR BARIATRIC SURGERY ON LOWERING BMI Z-SCORE IN OBESE SURVIVORS OF CHILDHOOD BRAIN TUMORS: A SYSTEMATIC REVIEW 2015
THE IMPACT OF AGE AND RACE ON LONGEVITY IN PEDIATRIC ASTROCYTIC TUMORS: A POPULATION-BASED STUDY 2015
TRADITIONAL AND COMPLEMENTARY MEDICINE STRATEGIES IN PAEDIATRIC ONCOLOGY: GLOBAL PATTERNS OF USE 2015
UTILIZATION OF THE WHO MODEL LIST OF ESSENTIAL MEDICINES (EML) FOR ANTI-NEOPLASTIC DRUGS IN LOW AND MIDDLE INCOME COUNTRIES (LMICS) 2015
BREAKING TRADITION: COMPLEMENTARY ROLE OF TRADITIONAL MEDICINE IN NATIONAL CANCER CONTROL PLANS GLOBALLY 2015
DIAGNOSIS OF UNSTABLE ALPHA CHAIN HEMOGLOBINOPATHIES IN THALASSEMIA INTERMEDIA 2015
CAREGIVER SELF-ADMINISTERED FINANCIAL EXPENDITURES (C-SAFE) FOR PEDIATRIC CANCER: ADAPTING AN ESTABLISHED INSTRUMENT 2014
EXPLORING CANCER WORRY PREDICTORS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD CANCERS 2014
FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS 2014
HEALTH-RELATED QUALITY OF LIFE IN A POPULATION-BASED SAMPLE OF SURVIVORS OF ADVANCED NEUROBLASTOMA IN CANADA 2014
INFERIOR SURVIVAL AMONG ABORIGINAL CHILDREN WITH CANCER IN ONTARIO 2014
IS THERE A ROLE FOR THROMBOPROPHYLAXIS IN PEDIATRIC SARCOMA PATIENTS? A LITERATURE REVIEW FOCUSING ON EPIDEMIOLOGY, RISK FACTORS AND OUTCOMES OF THROMBOEMBOLISM IN SARCOMA PATIENTS 2014
LACK OF TREATMENT-RELATED MORTALITY DEFINITIONS IN STUDIES OF CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS, SOLID TUMORS AND BRAIN TUMORS: A SYSTEMATIC REVIEW 2014
NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVORS WITH ATYPICAL TERATOID RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE 2014
PHYSICAL ACTIVITY SURVEY IN ADOLESCENTS WITH CANCER 2014
PROGRESSIVE DECLINE IN HEALTH-RELATED QUALITY OF LIFE AMONG LONG-TERM SURVIVORS OF BRAIN TUMOURS IN CHILDHOOD AND ADOLESCENCE 2014
PSYCHOLOGICAL DISTRESS, CAUSATION BELIEFS AMONG CAREGIVERS OF CHILDREN WITH CANCERS IN A DEVELOPING COUNTRY: INFLUENCE ON PATHWAY TO CARE AND TREATMENT UPTAKE 2014
QUALITY OF LIFE FROM THE PERSPECTIVE OF PEDIATRIC CANCER PATIENTS AND SURVIVORS: "THERE ARE GOOD THINGS AND THEN THERE ARE BAD THINGS" 2014
RESULTS OF PARENT SUPPORT GROUP AND HEALTH PROFESSIONAL SURVEYS ON KNOWLEDGE ABOUT AND ACCESS TO ESSENTIAL MEDICINES IN LOW/MIDDLE INCOME COUNTRIES (LMICS) 2014
RISK-TAKING BEHAVIOURS AMONG CHILDHOOD CANCER SURVIVORS: A META-ANALYSIS 2014
STANDARD RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN MOROCCO: EXPERIENCE OF 170 CASES TREATED IN A SINGLE CENTER 2014
SYMPTOMATIC THROMBOSIS IN LEBANESE CHILDREN WITH CANCER TREATED AT A TERTIARY CARE CENTER 2014
THE EFFECT OF CRANIAL RADIATION THERAPY (CRT) ON BODY MASS INDEX (BMI) DURING TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDREN: AN EXPLORATORY ANALYSIS 2014
THE FUNCTIONAL IMPACT OF PERIPHERAL NEUROPATHY IN CHILDREN AND YOUTH TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA: MULTIDIMENSIONAL ASSESSMENT 2014
UNTANGLING THE CORD: A POLICY ANALYSIS OF NATIONAL PUBLIC UMBILICAL CORD BLOOD BANKING IN CANADA 2014
HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM DANA-FARBER CANCER INSTITUTE (DFCI) ALL CONSORTIUM PROTOCOL 05-001 2014
LONG TERM CLINICAL AND NEUROCOGNITIVE OUTOMES OF HOMOZYGOUS ALPHA-THALASSEMIA SURVIVORS 2014
PREDICTORS OF CANCER DIAGNOSTIC INTERVALS AND ASSOCIATIONS WITH OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED COHORT STUDY USING HEALTH SERVICES DATA 2014
SURVIVAL OF CHILDREN WITH MEDULLOBLASTOMA IN CANADA DIAGNOSED BETWEEN 1990 AND 2010 2014
THE PATHOLOGY OF PEDIATRIC MEDULLOBLASTOMA IN CANADA: RESULTS OF A 20 YEAR EPIDEMIOLOGY STUDY 2014
DEVELOPMENT AND IMPLEMENTATION OF A CLINICALLY USEFUL MEASURE OF SOCIO-ECONOMIC STATUS FOR FAMILIES OF CHILDREN WITH CANCER IN GUATEMALA 2013
HEALTH STATUS AND HEALTH-RELATED QUALITY OF LIFE OF LONG-TERM SURVIVORS OF BRAIN TUMOURS IN CHILDHOOD 2013
INFECTIONS IN CHILDREN WITH DOWN SYNDROME AND ACUTE MYELOID LEUKEMIA: FROM THE CANADIAN INFECTIONS IN AML RESEARCH GROUP 2013
INITIAL DEVELOPMENT OF THE SYMPTOM SCREENING IN PEDIATRIC TOOL (SSPEDI) 2013
OBESITY AND IMMUNITY IN SURVIVORS OF CHILDHOOD BRAIN TUMORS: A PRELIMINARY REPORT 2013
PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) GUIDELINES FOR PREVENTION OF ANTINEOPLASTIC-INDUCED NAUSEA AND VOMITING (AINV) IN CHILDREN: ACUTE AND ANTICIPATORY AINV 2013
REPORT ON CURRENT ACTIVITIES OF THE INTERNATIONL PEDIATRIC ONCOLOGY NUTRITION GROUP (IPONG) 2013
THE DEVELOPMENT OF THROMBOEMBOLISM MAY INCREASE THE RISK OF OSTEONECROSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA 2013
WEEKLY VINBLASTINE IN CHEMOTHERAPY NAIVE CHILDREN WITH UNRESECTABLE OR PROGRESSIVE LOW GRADE GLIOMA: A CANADIAN COOPERATIVE STUDY 2013
COMBINED AUTOIMMUNE CYTOPENIAS PRESENTING IN CHILDHOOD: A RETROSPECTIVE CHART REVIEW 2013
INCIDENCE OF MEDULLOBLASTOMA IN CANADIAN CHILDREN 2013
MANAGEMENT OF FXIII DEFICIENCY: A REVIEW OF THE LITERATURE 2013
A DELINEATED UNIT ANALYSIS OF OUT OF POCKET EXPENSES INCURRED BY FAMILIES OF CHILDREN WITH CANCER 2012
A NEW QUESTIONNAIRE TO MEASURE TEEN-CENTRED CARE IN PEDIATRIC ONCOLOGY: GIVE YOUTH A VOICE 2012
CEREBRAL SINO-VENOUS THROMBOSIS IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY 2012
CHEMOTHERAPY PASSPORT: A TOOL TO IMPROVE SAFE DELIVERY OF CHEMOTHERAPY 2012
IDENTIFYING THE HEALTH AND SUPPORTIVE CARE NEEDS OF ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND SURVIVORS 2012
IMPORTANT FACTORS TO UNDERSTANDING QUALITY OF LIFE ACCORDING TO CHILDREN WITH CANCER AND CHILDHOOD CANCER SURVIVORS 2012
INSURANCE STATUS AND CANCER DISPARITIES IN ADOLESCENTS AND YOUNG ADULTS 15 TO 39 YEARS OF AGE, US NATIONAL CANCER DATA BASE, 1998-2003 2012
OUTCOME OF CHILDREN TREATED FOR RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA IN CENTRAL AMERICA 2012
SARCOPENIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA 2012
SURVEILLANCE AND SURVIVAL AMONG ADOLESCENTS AND YOUNG ADULTS WITH CANCER IN ONTARIO, CANADA 2012
TEEN-CENTRED CARE IS ASSOCIATED WITH TYPE OF CARE AND HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENT ONCOLOGY PATIENTS 2012
THE ROLE OF IMAGING IN DETECTING RELPASE IN PATIENTS WITH NEUROBLASTOMA. CAN POST-THERAPY SURVEILLANCE PROGRAMS BE SIMPLIFIED TO DECREASE RADIATION EXPOSURE? 2012
INCIDENCE OF VERTEBRAL FRACTURES IN CHILDREN WITH LEUKEMIA AFTER 12 MONTHS OF CHEMOTHERAPY 2011
PRESENTATION, TREATMENT AND OUTCOMES OF CHILDREN WITH CENTRAL NERVOUS SYSTEM GERMINOMAS: A SINGLE INSTITUTION EXPERIENCE 2011
THE CANADIAN TASK FORCE ON ADOLESCENTS AND YOUNG ADULTS (AYA) WITH CANCER; A PROCESS FOR CHANGE 2011
CORTICOSTEROIDS, BEHAVIOUR AND QUALITY OF LIFE IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA; A MULTI-CENTERED TRIAL 2011
DO NUCLEAR MEDICINE GFR STUDIES CONTRIBUTE TO THERAPEUTIC DECISION MAKING IN PEDIATRIC ONCOLOGY PATIENTS RECEIVING CHEMOTHERAPY? 2011
GROWING UP WITH HEMOPHILIA: AN ASSESSMENT OF TEENS' PERCEIVED NEEDS PRIOR TO TRANSITION 2011
SURFING FOR CANCER: PERSPECTIVES ON QUALITY AND CONTENT OF INFORMATION ON THE INTERNET FOR ADOLESCENT WITH CANCER 2011
A PROSPECTIVE MIXED METHODS STUDY TO DETERMINE THE COSTS INCURRED BY FAMILIES OF CHILDREN NEWLY DIAGNOSED WITH CANCER IN ONTARIO 2010
COMPARISON OF METHODS TO EVALUATE NUTRITIONAL STATUS IN A POPULATION OF CHILDREN WITH CANCER IN THE AHOPCA (ASOCIACION HEMATO-ONCOLOGIA PEDIATRICA DE CENTRO AMERICA Y DEL CARIBE) CONSORTIUM 2010
GROWTH IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) DURING TREATMENT 2010
LANGUAGE AND COMMUNICATION CHALLENGES EXPERIENCED BY CHINESE AND SOUTH ASIAN PARENTS OF CHILDREN WITH CANCER LIVING IN CANADA 2010
MANAGEMENT OF THROMBOEMBOLISM IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA 2010
PAIN MANAGEMENT AND OPIOIDS USE IN PAEDIATRIC ONCOLOGY IN INDIA: A QUALITATIVE APPROACH 2010
PERCEPTIONS ABOUT COMPLEMENTARY AND ALTERNATIVE MEDICINE USE AMONG CHINESE IMMIGRANT PARENTS OF CHILDREN WITH CANCER 2010
PROGNOSTIC FACTORS INFLUENCING SURVIVAL FOR CNS ATYPICAL TERATOID RHABDOID TUMORS IN BRITISH COLUMBIA 2010
THE USE OF ULTRASOUND AT DIAGNOSIS IN ENDEMIC BURKITT LYMPHOMA IN CAMEROON 2010
CD56 EXPRESSION AS A PROGNOSTIC INDICATOR IN PEDIATRIC AML: A SINGLE CENTRE REVIEW 2010
GLIOMATOSIS CEREBRI IN CHILDREN-A MULTIFACETED DISEASE 2010
REDEFINING THE INCIDENCE AND OUTCOMES OF CNS ATYPICAL TERATOID RHABDOID TUMOURS AT BC CHILDREN'S HOSPITAL 2010
COGNITION IMPAIRMENT AND QUALITY OF LIFE OF ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS 2009
DECREASED OVERALL SURVIVAL AND INCREASED RISK OF THROMBOSIS IN CHILDREN WITH CANCER AND CENTRAL VENOUS LINE (CVL) DYSFUNCTION 2009
NUTRITIONAL STATUS OF CHILDREN WITH CANCER IN COUNTRIES WITH LIMITED RESOURCES 2009
PREDICTORS OF BONY MORBIDITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA 2009
REVIEW AND ANALYSIS OF POSITIVE BLOOD CULTURES IN 248 CHILDREN DIAGNOSED WITH CANCER 2009
SERUM CREATININE AND LEAN BODY MASS DURING TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA 2009
ACINIC CELL CARCINOMA: CUT IT OUT ..... THEN WHAT? 2009
PREDICTORS OF OSTEOPENIA/OSTEOPOROSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA 2009
PREDICTORS OF OUTCOME, AND MICROBIOLOGY OF EPISODES OF FEBRILE NEUTROPENIA AMONG CHILDREN WITH CANCER IN EL SALVADOR, A LOW-INCOME COUNTRY 2009
Economic evaluation and health-related quality of life 2008
International Working Group on Adolescent/Teenage and Young Adult Oncology 2008
The role of bone marrow (BM) morphology in the diagnosis of hemophagocytic lymphohistiocytosis (HLH) 2007
Does mediastinal lymphadenopathy increase the risk of thromboembolism in children with lymphoma? 2007
Dosing and safety of unfractionated heparin in infants with thrombotic complications 2007
Early predictors of rapid disease progression in children with hemophagocytic lymphohistiocytosis 2007
Impact of a novel covalent antithrombin-heparin (ATH) on gene expression during epithelial branching of the developing mouse lung 2007
Impact of covalent anithrombin-heparin on vascularization in the developing lung 2007
Suboptimal dosing of enoxaparin in preterm infants 2007
Treatment decisions and outcome in hemophagocytic lymphohistiocytosis 2007
Nutritional status in children with cancer: A report from the AHOPCA workshop held in Guatemala City, August 31-September 5, 2004 2005
Cancer and the adolescent: The second teenage cancer trust international conference, royal college of physicians, London, England, March 2001 2002
Association Between Socioeconomic Factors and Childhood Acute Lymphoblastic Leukemia Treatment‐ and Survival‐Related Outcomes in Canada. 67:e31472. 2024
Hypoalbuminemia and Nutritional Status in Children with Cancer.. e31450. 2024
Clinical practice guideline-inconsistent chemotherapy-induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study.. 71:e31295. 2024
Sirolimus for vascular anomalies associated with PTEN hamartoma tumor syndrome.. 71:e31282. 2024
Clinical practice guideline‐inconsistent management of fever and neutropenia in pediatric oncology: A Children's Oncology Group study. 71:e30880. 2024
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–bone unit. 71:e30705. 2024
Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium. 70:e30560. 2023
Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population‐based cohort study. 70:e30610. 2023
The international scandal of defective asparaginase: A blight on children with cancer. 70:e30403. 2023
Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update. 70:e30395. 2023
Pediatric refractory immune thrombocytopenia: A systematic review. 70:e30173. 2023
Diagnosis and management of isolated neutropenia: A survey of pediatric hematologist oncologists.. 70:e29946. 2023
Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline. 69:e30001. 2022
Physiological stress reactivity in pediatric cancer survivors treated with chemotherapy. 69:e29881. 2022
Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in developing a single severity score for interventional clinical trials. 69:e29869. 2022
Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome. 69:e29829. 2022
Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer. 69:e29718. 2022
Thrombosis and hemorrhage experienced by hospitalized children with SARS‐CoV‐2 infection or MIS‐C: Results of the PICNIC registry. 69:e29793. 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001. 69:e29581. 2022
Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon. 69:e29675. 2022
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit. 69:e29668. 2022
Unilateral suprarenal hemorrhage in a teenager: A case of TAFRO. 69:e29475. 2022
A qualitative examination of the benefits and challenges of a psychosocial screening intervention in pediatric oncology: “Support comes to us”. 69:e29578. 2022
Altered mental status as a presentation of rhabdomyolysis in a patient with sickle cell anemia.. 69:e29386. 2022
Bloom where you are planted: Hemangioma or malignancy?. 69:e29485. 2022
Bone health in long‐term survivors of pediatric acute lymphoblastic leukemia. An assessment by peripheral quantitative computed tomography. 68:e29218. 2021
Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. 68:e29210. 2021
Phase‐specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group‐based treatment for childhood acute lymphoblastic leukemia: A population‐based study. 68:e29141. 2021
Efficacy of ready‐to‐use therapeutic food in malnourished children with cancer: Results of a randomized, open‐label phase 3 trial. 68:e29197. 2021
Pyruvate kinase deficiency in children. 68:e29148. 2021
Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update. 68:e28947. 2021
Corrigendum. 68:e28885. 2021
Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. 68:e28719. 2021
Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review. 67:e28716. 2020
Platelet transfusion practice and platelet refractoriness for a cohort of pediatric oncology patients: A single‐center study. 67:e28734. 2020
Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience. 67:e28477. 2020
Outcomes of children with chronic myeloid leukemia: A population‐based cohort study. 67:e28491. 2020
Nutritional traditional and complementary medicine strategies in pediatric cancer: A narrative review. 67:e28324. 2020
The influence of nutrition on clinical outcomes in children with cancer. 67:e28117. 2020
The relevance of nutrition to pediatric oncology: A cancer control perspective. 67:e28213. 2020
Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy. 67:e28179. 2020
Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature. 67:e28114. 2020
Recommendations for medical care in the pediatric oncology camp setting: Consensus statements based on Delphi methodology. 67:e28107. 2020
Analysis of factors that influence neurosurgical length of hospital stay among newly diagnosed pediatric brain tumor patients. 67:e28041. 2020
Validation of an algorithmic nutritional approach in children undergoing chemotherapy for cancer. 66:e27980. 2019
Colorectal cancer in adolescents and young adults: Defining a growing threat. 66:e27941. 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. 66:e27827. 2019
Health‐related quality of life in adolescents and young adults with cancer – Including a focus on economic evaluation. 66:e27808. 2019
Sport activities and exercise as part of routine cancer care in children and adolescents. 66:e27826. 2019
Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults. 66:e27660. 2019
Nutritional status at diagnosis of cancer in children and adolescents in Guatemala and its relationship to socioeconomic disadvantage: A retrospective cohort study. 66:e27647. 2019
Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. 66:e27646. 2019
Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy. 66:e27572. 2019
Erratum. 66:e27553. 2019
Erratum. 66:e27552. 2019
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. 66:e27540. 2019
Second rhabdoid tumor 8 years after treatment of atypical teratoid/rhabdoid tumor in a child with germline SMARCB1 mutation. 66:e27546. 2019
Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols. 66:e27483. 2019
A role for surgery in the treatment of relapsed Hodgkin lymphoma. 66:e27402. 2019
Genitopatellar syndrome and neuroblastoma: The multidisciplinary management of a previously unreported association. 65:e27373. 2018
Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001. 65:e27256. 2018
Acute myelogenous leukemia in adolescents and young adults. 65:e27089. 2018
Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype–phenotype correlation. 65:e27220. 2018
Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature. 65:e27225. 2018
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. 65:e27082. 2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. 65:e26952. 2018
Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation. 65:e26938. 2018
Pediatric oncology clinical trial participation where the geography is vast: Development of a clinical research system for tertiary and satellite centers in Ontario, Canada. 65. 2018
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001. 65. 2018
VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. 65. 2018
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. 64. 2017
Exercise interventions for patients with pediatric cancer during inpatient acute care: A systematic review of literature. 64. 2017
The clinical severity of hemoglobin S/Black (^Aγδβ)⁰‐thalassemia. 64. 2017
Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update. 64. 2017
Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy. 64. 2017
Evaluation of a joint adult and pediatric clinic for cancer survivorship care. 64. 2017
Global assessment of cancer incidence and survival in adolescents and young adults. 64. 2017
International evolution in AYA oncology: Current status and future expectations. 64. 2017
New horizons on the landscape of AYA oncology. 64. 2017
Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review. 64. 2017
Detection of a clone‐specific GATA1 mutation to monitor treatment response and involvement of a monozygotic twin in myeloid leukemia of Down syndrome. 64. 2017
The quality of information about sickle cell disease on the Internet for youth. 64:e26309-e26309. 2017
Health‐Related Quality of Life in Survivors of High‐Risk Neuroblastoma After Stem Cell Transplant: A National Population‐Based Perspective. 63:1615-1621. 2016
Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis. 63:1480-1483. 2016
Long-Term Social Outcomes of Hyperfractionated Radiation on Childhood ALL Survivors. 63:1445-1450. 2016
Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy‐Induced Nausea and Vomiting in Children With Cancer. 63:1144-1151. 2016
Smoking, Binge Drinking, and Drug Use Among Childhood Cancer Survivors: A Meta-Analysis. 63:1254-1263. 2016
Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group. 63:973-982. 2016
Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease. 63:983-989. 2016
Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries. 63:287-291. 2016
Combined Autoimmune Cytopenias Presenting in Childhood. 63:292-298. 2016
Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP). 62:2223-2225. 2015
Medicines for cancers in children: The WHO model for selection of essential medicines. 62:1689-1693. 2015
The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia. 62:1851-1854. 2015
The impact of age and race on longevity in pediatric astrocytic tumors: A population‐based study. 62:1567-1571. 2015
Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience. 62:1265-1269. 2015
Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia. 62:957-963. 2015
Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome. 62:854-858. 2015
Hematopoietic stem cell transplantation in infants. 62:517-521. 2015
Measurement of socio‐economic status in families of children with cancer in Guatemala. 61:2071-2073. 2014
Reply to comment: Asociación de Hemato‐Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology. 61:2122-2122. 2014
Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. 61:1506-1512. 2014
Improved treatment results of children with B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B‐NHL03 study. 61:1215-1221. 2014
Outcome of children treated for relapsed acute myeloid leukemia in Central America. 61:1222-1226. 2014
Camp programs for children with cancer and their families: Review of research progress over the past decade. 61:778-787. 2014
Beyond the bench and the bedside: Economic and health systems dimensions of global childhood cancer outcomes. 61:572-576. 2014
Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology. 61:345-354. 2014
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01. 60:1785-1791. 2013
Novel dominant β‐thalassemia: Hb Boston‐Kuwait [Codon 139/140(+T)]. 60:E131-E134. 2013
Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma. 60:1636-1641. 2013
Hemoglobin shady grove: A novel fetal methemoglobin variant. 60:E55-E56. 2013
Massive splenic infarction in an adolescent with hemoglobin S‐HPFH. 60:E49-E51. 2013
Psychological resilience in adolescent and young adult survivors of lower extremity bone tumors. 60:1223-1230. 2013
Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. 60:911-915. 2013
Essential medicines for children with cancer. 60:888-888. 2013
Essential medicines for pediatric oncology in developing countries. 60:889-891. 2013
A mixed method approach to describe the out‐of‐pocket expenses incurred by families of children with cancer. 60:438-445. 2013
Positioning new treatments in the management of immune thrombocytopenia. 60:S19-S22. 2013
Severe fetal and neonatal hemolytic anemia due to a 198 kb deletion removing the complete β‐globin gene cluster. 59:941-944. 2012
Health‐related quality of life among children with acute lymphoblastic leukemia. 59:717-724. 2012
Body mass index and thromboembolism in children with hematological malignancies. 59:320-322. 2012
Predictors of bony morbidity in children with acute lymphoblastic leukemia. 59:77-82. 2012
Meeting report: Development of an international committee on nutrition & health for children with cancer, international society of pediatric oncology (SIOP). 58:1008-1009. 2012
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana‐Farber ALL consortium protocol 95‐01 at 5 years post‐diagnosis. 58:758-765. 2012
Communication and language challenges experienced by Chinese and South Asian immigrant parents of children with cancer in Canada: Implications for health services delivery. 58:572-578. 2012
The use of ultrasound in endemic Burkitt lymphoma in Cameroon. 58:352-355. 2012
Health related quality of life in adolescent and young adult survivors of lower extremity bone tumors. 58:265-273. 2012
Impact of caring for a child with cancer on single parents compared with parents from two‐parent families. 58:74-79. 2012
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age‐dependent: Report from Dana‐Farber Cancer Institute ALL Consortium Protocol 00‐01. 57:492-498. 2011
Perspectives on quality and content of information on the internet for adolescents with cancer. 57:97-104. 2011
Children receiving treatment for cancer and their caregivers: A mixed methods study of their sleep characteristics. 56:638-645. 2011
Sexual function in adolescent and young adult survivors of lower extremity bone tumors. 55:1370-1376. 2010
PET imaging for pediatric oncology: An assessment of the evidence. 55:1048-1061. 2010
Successful treatment of multiply relapsed lymphoma with rituximab as a single agent. 55:356-358. 2010
Imatinib mesylate in children and adolescents with cancer. 55:18-25. 2010
Von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: An impact of peripheral blasts. 54:963-969. 2010
Pre‐transplant lung function is predictive of survival following pediatric bone marrow transplantation. 54:454-460. 2010
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. 54:199-205. 2010
Factors affecting the delivery of family‐centered care in pediatric oncology. 53:1079-1085. 2009
Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology–oncology specialists. 53:960-966. 2009
The use of elastic compression stockings for post‐thrombotic syndrome in a child. 53:462-463. 2009
Optimal care for the child with cancer: A summary statement from the SIOP working committee on psychosocial issues in pediatric oncology. 52:904-907. 2009
Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. 51:792-797. 2008
Pediatric oncology sedation trial (POST): A double‐blind randomized study. 51:634-638. 2008
Delays in diagnosis and treatment among children and adolescents with cancer in Canada. 51:468-474. 2008
The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. 51:402-404. 2008
Creatine monohydrate attenuates body fat accumulation in children with acute lymphoblastic leukemia during maintenance chemotherapy. 51:183-187. 2008
Communicating with the dying child: An invitation to listening—a report of the SIOP working committee on psychosocial issues in pediatric oncology. 50:1087-1088. 2008
Self and proxy‐reported health status and health‐related quality of life in survivors of childhood cancer in Uruguay. 50:838-843. 2008
Complementary and alternative medicines, dietary manipulation and vitamin supplementation. 50:498-498. 2008
Nutrition and cancer in children. 50:437-437. 2008
Nutritional status: Measurements and outcomes. 50:451-451. 2008
Osteonecrosis in children and adolescents with cancer. 50:483-485. 2008
The Canadian Childhood Cancer Surveillance and Control Program (CCCSCP): A status report. 50:518-519. 2008
Vitamin D status and bone biomarkers in childhood cancer. 50:479-482. 2008
β‐thalassemia intermedia due to compound heterozygosity for two β‐globin gene promoter mutations, including a novel TATA box deletion. 50:363-366. 2008
Difficult beginnings—Cancer in infancy. 49:1059-1059. 2007
Evidence about HUI and hemophilia in response to Young et al. “How well does the Canadian hemophilia outcomes‐kids' life assessment tool (CHO‐KLAT) measure the quality of life of boys with hemophilia?”. 49:1047-1048. 2007
Global issues and opportunities for optimized retinoblastoma care. 49:1083-1090. 2007
Sickle cell disease caused by Hb S/Québec‐CHORI: Treatment with hydroxyurea and response. 49:207-210. 2007
Thromboembolism in children with sarcoma. 49:171-176. 2007
Implementation of a data management program in a pediatric cancer unit in a low income country. 49:23-27. 2007
Protocol‐based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—Part II. 48:486-490. 2007
Improving outcomes for children with cancer in low‐income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)‐Part I. 48:364-369. 2007
Hospital and home chemotherapy for children with leukemia: A randomized cross‐over study. 47:285-292. 2006
Cancer surveillance and control in adolescents—similarities and contrasts between Canada and the United States. 46:273-277. 2006
Osteopenia, physical activity and health‐related quality of life in survivors of brain tumors treated in childhood. 46:357-362. 2006
AMOR: A proposed cooperative effort to improve outcomes of childhood cancer in Central America. 45:107-110. 2005
Serum creatinine: A surrogate measurement of lean body mass in children with acute lymphoblastic leukemia. 45:16-19. 2005
A formulary for pediatric oncology in developing countries. 44:433-435. 2005
Waiting times for cancer care in Canadian children: Impact of distance, clinical, and demographic factors. 44:318-327. 2005
Quality‐adjusted survival: A rigorous assessment of cure after cancer during childhood and adolescence. 44:201-204. 2005
Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone forpneumocystis carinii pneumonia (PCP) prophylaxis: A correlation with cytochrome b5 reductase (Cb5R) enzyme levels. 44:55-62. 2005
A survey of resources and activities in the MISPHO family of institutions in Latin America: A comparison of two eras. 43:758-764. 2004
Health status of young children during therapy for advanced neuroblastoma. 43:659-667. 2004
Challenges to the measurement of health‐related quality of life in children receiving cancer therapy. 43:215-223. 2004
Selective thrombocytopenia in children with Wilms tumor: An immune‐mediated effect of dactinomycin?. 41:483-485. 2003
Nutrition and cancer in children. 41:54-57. 2003
Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate. 39:44-46. 2002
Childhood cancer in Uruguay: 1992–1994. Incidence and mortality. 37:400-404. 2001
Pediatric oncology in developing countries: Development of an alliance of stakeholders. 36:305-309. 2001
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. 33:99-105. 1999
Open‐label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. 33:99-105. 1999
A special niche forMPO. 32:403-403. 1999
On cancer control and the adolescent. 32:404-410. 1999
Limitation of ankle range of motion in survivors of acute lymphoblastic leukemia: A cross-sectional study. 32:279-282. 1999
Long-term gross motor performance following treatment for acute lymphoblastic leukemia. 31:86-90. 1998
Impact of age and cranial irradiation on radiographic skeletal pathology in children with acute lymphoblastic leukemia. 30:347-350. 1998
Multiattribute approach to the assessment of health-related quality of life: Health utilities index. 30:54-59. 1998
Poland's syndrome and Wilms tumor: An unusual association. 30:67-68. 1998
Cardiorespiratory status after treatment for acute lymphoblastic leukemia. 26:160-165. 1996
Child with Wilms' tumor and von Willebrand disease at diagnosis and apparent complete response to chemotherapy after multiple relapses. 26:64-69. 1996
Childhood medulloblastoma in Ontario, 1977–1987: Population-based results. 26:1-9. 1996
Late recurrence in Hodgkin's disease: A report of two cases. 12:148-149. 1984
Retinoblastoma, eosinophilic granuloma, and malignant melanoma: A case report. 12:347-348. 1984
The chemotherapy of granulosa cell tumors of the ovary: Experience of the wisconsin clinical cancer center. 12:397-400. 1984

Pediatric Blood and Cancer Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)